Recombinant staphylokinase (Chinese Academy Of Sciences/Chengdu Jinpeng)

重组葡激酶（中国科学院/成都金鹏）

Report date: 2025/06/26 15:45:19

Base Information

Drug NameRecombinant staphylokinase (Chinese Academy Of Sciences/Chengdu Jinpeng)
Drug Alias Name施爱克
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsMyocardial Infarction
Approved Indications in ChinaMyocardial Infarction
Original Approved Country/TerritoryMainland China
Original Approved Date2003/07/25
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Institute Of Plant Physiology Chinese Academy Of SciencesChengdu Jinpeng Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Institute Of Plant Physiology Chinese Academy Of SciencesChengdu Jinpeng Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A